Critical molecular pathways in cancer stem cells of chronic myeloid leukemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/leu2010143.pdf
Reference118 articles.
1. Mughal TI, Yong A, Szydlo RM, Dazzi F, Olavarria E, van Rhee F et al. Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse. Br J Haematol 2001; 115: 569–574.
2. Goldman J . Allogeneic stem cell transplantation for chronic myeloid leukemia—status in 2007. Bone Marrow Transplant 2008; 42 (Suppl 1): S11–S13.
3. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038–1042.
4. Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408–2417.
5. Bhatia R, Holtz M, Niu N, Gray R, Snyder DS, Sawyers CL et al. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 2003; 101: 4701–4707.
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. BCR-ABL triggers a glucose-dependent survival program during leukemogenesis through the suppression of TXNIP;Cell Death & Disease;2023-04-24
2. A Dual Level Analysis with Evolutionary Computing and Swarm Models for Classification of Leukemia;BioMed Research International;2022-05-26
3. Signal-transducing adaptor protein-1 and protein-2 in hematopoiesis and diseases;Experimental Hematology;2022-01
4. Sphingosine kinases are involved in the regulation of all‑trans retinoic acid sensitivity of K562 chronic myeloid leukemia cells;Oncology Letters;2021-06-02
5. A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia;Hematologic Malignancies;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3